Skip to main content

Tables 4 Mean changes in metabolic indicators at the baseline and end of trial

From: Clinical and metabolic response to soy administration in older women with metabolic syndrome: a randomized controlled trial

Metabolic indicators Mean change
Soy-nut TSP Control P value
TC (mg/dl) − 29.2 ± 3.56a,c − 24.3 ± 3.54a,c − 8.7 ± 5.47 < 0.01
TG (mg/dl) − 12.2 ± 1.86c − 11.6 ± 1.95c − 4.1 ± 1.12 0.14
HDL-C (mg/dl) 2.1 ± 0.49c 1.7 ± 0.64c − 0.57 ± 1.46 0.10
LDL-C (mg/dl) − 23.1 ± 2.03a,c − 20.1 ± 3.00a,c − 0.80 ± 3.84 < 0.001
VLDL-C (mg/dl) − 7.1 ± 1.11a,c − 5.0 ± 0.67a,c − 0.37 ± 1.23 < 0.001
Apo AI (g/l) 0.19 ± 0.03a,c 0.18 ± 0.03a,c − 0.02. ± 0.01 < 0.01
Apo B100(g/l) − 0.31 ± 0.04a,c − 0.28 ± 0.01a,c 0.06 ± 0.05 < 0.001
FBG (mg/dl) − 14.4 ± 1.10b,c − 6.5 ± 0.60c − 2.8 ± 1.54 < 0.001
Insulin (µIU/ml) − 2.0 ± 0.29b,c − 0.8 ± 0.20a,c 0.4 ± 0.22 < 0.001
HOMA-IR − 0.9 ± 0.08b,c − 0.4 ± 0.06a,c − 0.02 ± 0.07 < 0.001
TG/HDL − 0.5 ± 0.08a,c − 0.4 ± 0.09a,c 0.03 ± 0.21 < 0.01
CRP (µg/ml) − 0.25 ± 0.16 − 0.16 ± 0.17 − 0.04 ± 0.32 0.8
Fibrinogen (mg/dl) − 18.8 ± 8.98 − 14.5 ± 9.53 − 7.8 ± 6.24 0.65
MDA (µmol/l) − 0.75 ± 0.04a,c − 0.63 ± 0.07a,c − 0.01 ± 0.08 < 0.001
TAC (µmol/l) 214.2 ± 20.02a,c 198.0 ± 23.47a,c 45.1 ± 19.34 < 0.001
  1. Values are mean ± standard error
  2. TSP: Textured soy protein; SBP: systolic blood pressure; DBP: diastolic blood pressure; TC: total cholesterol; TG: triglyceride; HDL-C: high density lipoprotein; LDL-C: low density lipoprotein; VLDL-C: very low density lipoprotein; Apo AI: apolipoprotein AI; Apo B100: apolipoprotein B100; FBG: fasting blood glucose; HOMA-IR: homeostasis model of assessment insulin resistance; TG/HDL-C: triglyceride/high density lipoprotein; MDA: malondialdehyde; TAC: total antioxidant capacity; CRP: C-reactive protein
  3. aThere was a significant difference in the treatment groups compared with control group (post hoc ANOVA)
  4. bThere was a significant difference in the soy-nut group compared with TSP and control groups (post hoc ANOVA)
  5. cFor significant changes after-before (paired t-test)